%0 Journal Article %J The New England journal of medicine %D 2010 %T Timing of initiation of antiretroviral drugs during tuberculosis therapy. %A Abdool Karim, Salim S %A Naidoo, Kogieleum %A Grobler, Anneke %A Padayatchi, Nesri %A Baxter, Cheryl %A Gray, Andrew %A Gengiah, Tanuja %A Nair, Gonasagrie %A Bamber, Sheila %A Singh, Aarthi %A Khan, Munira %A Pienaar, Jacqueline %A El-Sadr, Wafaa %A Friedland, Gerald %A Abdool Karim, Quarraisha %K Adult %K AIDS-Related Opportunistic Infections %K Anti-Retroviral Agents %K Antitubercular Agents %K CD4 Lymphocyte Count %K Drug Administration Schedule %K Drug Therapy, Combination %K Female %K Follow-Up Studies %K HIV %K HIV Infections %K Humans %K Kaplan-Meier Estimate %K Male %K Middle Aged %K Patient Compliance %K RNA, Viral %K Tuberculosis %K Viral Load %K Young Adult %N 8 %P 697-706 %R 10.1007/s10461-009-9532-3 %V 362 %X The rates of death are high among patients with coinfection with tuberculosis and the human immunodeficiency virus (HIV). The optimal timing for the initiation of antiretroviral therapy in relation to tuberculosis therapy remains controversial. %8 2010 Feb 25